PSMG2 and neoplasm: Consistent with this, downregulation of PSMG2 in the HNSCC cell lines RPMI-2650 and Detroit-562 led to a significant reduction in proliferation in vitro and tumor growth in vivo, further supporting its potential as a prognostic biomarker and therapeutic target for these tumors.